BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14670301)

  • 1. Activation of autoreactive B cells by CpG dsDNA.
    Viglianti GA; Lau CM; Hanley TM; Miko BA; Shlomchik MJ; Marshak-Rothstein A
    Immunity; 2003 Dec; 19(6):837-47. PubMed ID: 14670301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.
    Uccellini MB; Busconi L; Green NM; Busto P; Christensen SR; Shlomchik MJ; Marshak-Rothstein A; Viglianti GA
    J Immunol; 2008 Nov; 181(9):5875-84. PubMed ID: 18941176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes.
    Avalos AM; Kiefer K; Tian J; Christensen S; Shlomchik M; Coyle AJ; Marshak-Rothstein A
    Autoimmunity; 2010 Feb; 43(1):103-10. PubMed ID: 20014975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
    Marshak-Rothstein A; Busconi L; Lau CM; Tabor AS; Leadbetter EA; Akira S; Krieg AM; Lipford GB; Viglianti GA; Rifkin IR
    J Endotoxin Res; 2004; 10(4):247-51. PubMed ID: 15373969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
    Avalos AM; Latz E; Mousseau B; Christensen SR; Shlomchik MJ; Lund F; Marshak-Rothstein A
    J Immunol; 2009 Nov; 183(10):6262-8. PubMed ID: 19864612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary development and participation in a foreign antigen-driven immune response of a chromatin-reactive B cell clonotype are not influenced by TLR9 or other MyD88-dependent TLRs.
    Coffey F; Liu X; Manser T
    J Immunol; 2007 Nov; 179(10):6663-72. PubMed ID: 17982056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
    Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
    Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.
    Avalos AM; Uccellini MB; Lenert P; Viglianti GA; Marshak-Rothstein A
    Eur J Immunol; 2010 Oct; 40(10):2692-8. PubMed ID: 20809520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
    Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
    Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
    Busconi L; Bauer JW; Tumang JR; Laws A; Perkins-Mesires K; Tabor AS; Lau C; Corley RB; Rothstein TL; Lund FE; Behrens TW; Marshak-Rothstein A
    J Immunol; 2007 Dec; 179(11):7397-405. PubMed ID: 18025183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
    Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
    Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
    Rui L; Vinuesa CG; Blasioli J; Goodnow CC
    Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
    Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
    J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors and activation of autoreactive B cells.
    Leadbetter EA; Rifkin IR; Marshak-Rothstein A
    Curr Dir Autoimmun; 2003; 6():105-22. PubMed ID: 12408049
    [No Abstract]   [Full Text] [Related]  

  • 17. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.
    Yasuda K; Richez C; Uccellini MB; Richards RJ; Bonegio RG; Akira S; Monestier M; Corley RB; Viglianti GA; Marshak-Rothstein A; Rifkin IR
    J Immunol; 2009 Sep; 183(5):3109-17. PubMed ID: 19648272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus.
    Sang A; Zheng YY; Choi SC; Zeumer L; Morel L
    J Leukoc Biol; 2015 Aug; 98(2):209-21. PubMed ID: 25957308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence.
    Uccellini MB; Busto P; Debatis M; Marshak-Rothstein A; Viglianti GA
    Immunol Lett; 2012 Mar; 143(1):85-91. PubMed ID: 22285306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.